Nothing new, Takeda needs to bring back Omontys. and relaunch it. One of the Blockbuster drugs in their pipeline. It is foolhardy to think they will abandon the drug after this much of time, effort and money spent.
Getting FDA approval is not an easy thing and they won't #$%$ it off.